Etiology of gastric cancer: What is new?

Cancer Epidemiology Biomarkers and Prevention

Volumn 14, Issue 8, 2005, Pages 1865-1868

  Correa, Pelayo ^a   Schneider, Barbara G ^a  

^a LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAGA PROTEIN; CYTOKINE; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 1BETA;

BACTERIAL GENOME; BACTERIAL VIRULENCE; CANCER RISK; CANCER SUSCEPTIBILITY; GASTROINTESTINAL INFECTION; GENETIC POLYMORPHISM; HELICOBACTER PYLORI; HUMAN; IMMUNE RESPONSE; INFLAMMATION; MODULATION; NONHUMAN; PRIORITY JOURNAL; REVIEW; STOMACH CANCER;

ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; HELICOBACTER PYLORI; HUMANS; INFLAMMATION; INTERLEUKIN-13; POLYMORPHISM, GENETIC; RISK FACTORS; STOMACH NEOPLASMS; VARIATION (GENETICS);

EID: 23844458889     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-05-0029     Document Type: Review

References (52)

1. Parkin DM. International variation. Oncogene 2004;23:6329-40.
2. El-Serag HB, Mason AC, Petersen N, Key CR. Epidemiological differences between adenocarcinoma of the oesophagus and adenocarcinoma of the gastric cardia in the USA. Gut 2002;50:368-72.
3. Corley DA, Kubo A. Influence of site classification of cancer incidence rates: an analysis of gastric cardia carcinomas. J Natl Cancer Inst 2004;96:1383-7.
4. Devesa SS, Blot WJ, Fraumeni JF Jr. Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer 1998;83:2049-53.
5. Henson DE, Dittus C, Younes M, Nguyen H, Albores-Saavedra J. Differential trends in the intestinal and diffuse types of gastric carcinoma in the United States, 1973-2000: increase in the signet ring cell type. Arch Pathol Lab Med 2004;128:765-70.
6. Coleman MP, Esteve J, Damiecki P, Arslan A, Renard H. Chapter 10. Stomach. Trends in cancer incidence and mortality. Vol. 121, Lyon: IARC; 1993. p. 193-224.
7. Verdecchia A, Mariotto A, Gatta G, Bustamante-Teixeira MT, Ajiki W. Comparison of stomach cancer incidence and survival in four continents. Eur J Cancer 2003;39:1603-9.
8. IARC monograph on the evaluation of carcinogenic risks to humans: schistosomes, liver flukes and Helicobacter pylori. Lyon: IARC; 1994.
9. El-Omar EM, Carrington M, Chow WH, et al. Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature 2000;404:398-402.
10. El-Omar EM, Rabkin CS, Gammon MD, et al. Increased risk of noncardia gastric cancer associated with proinflammatory cytokine gene polymorphisms. Gastroenterol 2003;124:1193-201.
11. Machado JC, Pharoah P, Sousa S, et al. Interleukin 1B and interleukin 1RN polymorphisms are associated with increased risk of gastric carcinoma. Gastroenterology 2001;121:823-9.
12. Figueiredo C, Machado JC, Pharoah P, et al. Helicobacter pylori and interleukin 1 genotyping: an opportunity to identify high-risk individuals for gastric carcinoma. J Natl Cancer Inst 2002;94:1680-7.
13. Zeng ZR, Hu PJ, Hu S, et al. Association of interleukin 1B gene polymorphism and gastric cancers in high and low prevalence regions in China. Gut 2003;52:1684-9.
14. Tseng LH, Chen PJ, Lin MT, et al. Single nucleotide polymorphisms in intron 2 of the human interleukin-1 receptor antagonist (IL-1Ra) gene: further definition of the IL-1 beta and IL-1Ra polymorphisms in North American Caucasians and Taiwanese Chinese. Tissue Antigens 2001;57:318-24.
15. Go MF, Kapur V, Graham DY, Musser JM. Population genetic analysis of Helicobacter pylori by multilocus enzyme electrophoresis: extensive allelic diversity and recombinational population structure. J Bacteriol 1996;178:3934-8.
16. Blaser MJ, Berg DE. Helicobacter pylori genetic diversity and risk of human disease. J Clin Invest 2001;107:767-73.
17. Kim S, Chamberlain AK, Bowie JU. Membrane channel structure of Helicobacter pylori vacuolating toxin: role of multiple GXXXG motifs in cylindrical channels. Proc Nat Acad Sci U S A 2004;101:5988-91.
18. Szabo I, Brutsche S, Tombola F, et al. Formation of anion-selective channels in the cell plasma membrane by the toxin VacA of Helicobacter pylori is required for its biological activity. EMBO J 1999;18:5517-27.
19. Peek RMJ, Blaser MJ, Mays DJ, et al. Helicobacter pylori strain-specific genotypes and modulation of the gastric epithelial cell cycle. Cancer Res 1999;59:6124-31.
20. Galmiche A, Rassow J, Doye A, et al. The N-terminal 34 kDa fragment of Helicobacter pylori vacuolating cytotoxin targets mitochondria and induces cytochrome c release. EMBO J 2000;19:6361-70.
21. Kuck D, Kolmerer B, Iking-Konert C, et al. Vacuolating cytotoxin of Helicobacter pylori induces apoptosis in the human gastric epithelial cell line AGS. Infect Immun 2001;69:5080-7.
22. Willhite DC, Cover TL, Blanke SR. Cellular vacuolation and mitochondrial cytochrome c release are independent outcomes of Helicobacter pylori vacuolating cytotoxin activity that are each dependent on membrane channel formation. J Biol Chem 2003;278:48204-9.
23. Fujikawa A, Shirasaka D, Yamamoto S, et al. Mice deficient in protein tyrosine phosphatase receptor type Z are resistant to gastric ulcer induction by VacA of Helicobacter pylori. Nat Genet 2003;33:375-81.
24. Gebert B, Fischer W, Weiss E, Hoffmann R, Haas R. Helicobacter pylori vacuolating cytotoxin inhibits T lymphocyte activation. Science 2003;301:1099-102.
25. Atherton JC, Sharp PM, Cover TL, et al. Vacuolating cytotoxin (vacA) alleles of Helicobacter pylori comprise two geographically widespread types, m1 and m2, and have evolved through limited recombination. Curr Microbiol 1999; 39:211-8.
26. van Doom L-J, Figueiredo C, Sanna R, et al. Expanding allelic diversity of Helicobacter pylori vacA. J Clin Microbiol 1998;36:2597-603.
27. Cover TL, Dooley CP, Blaser MJ. Characterization of and human serologic response to proteins in Helicobacter pylori broth culture supernatants with vacuolizing cytotoxin activity. Infect Immun 1990;58:603-11.
28. Tummuru MKR, Cover TL, Blaser MJ. Cloning and expression of a high-molecular mass major antigen of Helicobacter pylori: evidence of linkage to cytotoxin production. Inf Immun 1993;61:1799-809.
29. Covacci A, Censini S, Bugnoli M, et al. Molecular characterization of the 128-kDa immunodominant antigen of Helicobacter pylori associated with cytotoxicity and duodenal ulcer. Proc Nat Acad Sci U S A 1993;90:5791-5.
30. Xiang ZY, Censini S, Bayeli PF, et al. Analysis of expression of CagA and VacA virulence factors in 43 strains of Helicobacter pylori reveals that clinical isolates can be divided into two major types and that CagA is not necessary for expression of the vacuolating cytotoxin. Infect Immun 1995;63:94-8.
31. Blaser MJ, Perez-Perez GI, Kleanthou TL, et al. Infection with Helicobacter pylori strains possessing cagA is associated with an increased risk of developing adenocarcinoma of the stomach. Cancer Res 1995;55:2111-5.
32. Rugge M, Busatto G, Cassaro M, et al. Patients younger than 40 years with gastric carcinoma: Helicobacter pylori genotype and associated gastritis phenotype. Cancer 1999;85:2506-11.
33. Parsonnet J, Friedman GD, Orentreich N, Vogelman H. Risk for gastric cancer in people with CagA positive or CagA negative Helicobacter pylori infection. Gut 1997;40:297-301.
34. Segal ED, Cha J, Lo J, Falkow S, Tompkins LS. Altered states: involvement of phosphorylated CagA in the induction of host cellular growth changes by Helicobacter pylori. Proc Nat Acad Sci U S A 1999;96:14559-64.
35. Asahi M, Azuma T, Ito S, et al. Helicobacter pylori CagA protein can be tyrosine phosphorylated in gastric epithelial cells. J Exp Med 2000;191:593-602.
36. Odenbreit S, Puls J, Sedlmaier B, et al. Translocation of Helicobacter pylori CagA into gastric epithelial cells by type IV secretion. Science 2000;287:1497-500.
37. Stein M, Rappuoli R, Covacci A. Tyrosine phosphorylation of the Helicobacter pylori CagA antigen after cag-driven host cell translocation. Proc Natl Acad Sci U S A 2000;97:1263-8.
38. Backert S, Ziska E, Brinkmann V, et al. Translocation of the Helicobacter pylori CagA protein in gastric epithelial cells by a type IV secretion apparatus. Cell Microbiol 2000;2:155-64.
39. Rieder G, Hatz RA, Moran AP, et al. Role of adherence in interleukin-8 induction in Helicobacter pylori-associated gastritis. Infect Immun 1997;65:3622-30.
40. Audibert C, Burucoa C, Janvier B, Fauchère JL. Implication of the structure of the Helicobacter pylori cag pathogenicity island in induction of interleukin-8 secretion. Infect Immun 2001;69:1625-9.
41. Censini S, Lange C, Xiang Z, et al. cag, a pathogenicity island of Helicobacter pylori, encodes type I-specific and disease-associated virulence factors. Proc Natl Acad Sci U S A 1996;93:14648-53.
42. Keates S, Hitti YS, Upton M, Kelly CP. Helicobacter pylori infection activates NF-κ B in gastric epithelial cells. Gastroenterol 1997;113:1099-109.
43. Foryst-Ludwig A, Naumann M. p21-activated kinase 1 activates the nuclear factor κB (NF-κB)-inducing kinase-IκB kinases NF-κB pathway and proinflammatory cytokines in Helicobacter pylori infection. J Biol Chem 2000;275:39779-85.
44. Selbach M, Moese S, Hauck CR, Meyer TF, Backert S. Src is the kinase of the Helicobacter pylori CagA protein in vitro and in vivo. J Biol Chem 2002;277:6775-8.
45. Stein M, Bagnoli F, Halenbeck R, et al. c-Src/Lyn kinases activate Helicobacter pylori CagA through tyrosine phosphorylation of the EPIYA motifs. Mol Microbiol 2002;43:971-80.
46. Higashi H, Tsutsumi R, Muto S, et al. SHP-2 tyrosine phosphatase as an intracellular target of Helicobacter pylori CagA protein. Science 2002;295:683-6.
47. Yamaoka Y, Kodama T, Kashima K, Graham DY, Sepulveda AR. Variants of the 3′ region of the cagA gene in Helicobacter pylori isolates from patients with different H pylori-associated diseases. J Clin Microbiol 1998; 36:2258-63.
48. Yamaoka Y, El-Zimaity HMT, Gutierrez O, et al. Relationship between the cagA 3′ repeat region of Helicobacter pylori, gastric histology, and susceptibility to low pH. Gastroenterol 1999;117:342-9.
49. Blomstergren A, Lundin A, Nilsson C, Engstrand L, Lundeberg J. Comparative analysis of the complete cag pathogenicity island sequence in four Helicobacter pylori isolates. Gene 2004;328:85-93.
50. Higashi H, Tsutsumi R, Fujita A, et al. Biological activity of the Helicobacter pylori virulence factor CagA is determined by variation in the tyrosine phosphorylation sites. Proc Nat Acad Sci U S A 2002;99:14428-33.
51. Azuma T, Yamazak IS, Yamakawa A, et al. Association between diversity in the Src homology 2 domain-containing tyrosine phosphatase binding site of Helicobacter pylori CagA protein and gastric atrophy and cancer. J Infect Dis 2004;189:820-7.
52. Argent RH, Kidd MS, Owen RJ, et al. Determinants and consequences of different levels of CagA phosphorylation for clinical isolates of Helicobacter pylori. Gastroenterol 2004;127:514-23.